STOCK TITAN

Atea Pharmaceuticals director proposes $60.8K sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Atea Pharmaceuticals, Inc. (AVIR) director Bruce Polsky reported a proposed sale of 14,254 common shares, with an aggregate market value of $60,840.35 and an approximate sale date of November 16, 2026.

Shares proposed for sale 14,254 shares Approximate sale date November 16, 2026
Aggregate market value $60,840.35 For the 14,254 common shares proposed for sale
Shares outstanding 80,304,145 shares Reported shares outstanding for Atea Pharmaceuticals, Inc.
Stock Option Exercise financial
"Nature of Acquisition Transaction: Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AVIR shares does Bruce Polsky propose to sell, and what is their reported value?

Bruce Polsky reported a proposed sale of 14,254 common shares with an aggregate market value of $60,840.35. The approximate sale date is November 16, 2026.

How did Bruce Polsky acquire the AVIR shares listed for sale?

He acquired the 14,254 shares from the issuer through a stock option exercise on November 16, 2026, with cash listed as the payment method.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading